Correction
==========

Following the publication of our article \[[@B1]\], it has come to our attention that there was an error with the values listed for Ziprasidone and Aripiprazole in Table Ten. Table Ten should therefore appear as shown in this correction (Table [1](#T1){ref-type="table"}).

###### 

Mean annual number of stable days and cost per patient by pharmaceutical treatment.

                                                                      **Paliperidone ER**   **Olanzapine**   **Risperidone**   **Quetiapine**   **Ziprasidone**   **Aripiprazole**
  ------------------------------------------------------------------- --------------------- ---------------- ----------------- ---------------- ----------------- ------------------
  Base case:                                                                                                                                                      
  Cost (€)                                                            7.030                 7.034            7.082             8.321            7.807             7.713
  Effectiveness                                                       272.5                 272.2            265.5             260.7            258.6             260.5
                                                                                                                                                                  
  Incremental cost and effectiveness compared with paliperidone ER:                                                                                               
  Cost (€)                                                            \-                    4                52                1.291            777               683
  Effectiveness                                                       \-                    -0.3             -7.0              -11.8            -13.9             -12.0
